8-K - Drugs Made In America Acquisition II Corp. (0002040475) (Filer)
Published . Updated .
Key takeaways
- 8-K - Drugs Made In America Acquisition II filed an 8-K with the SEC on Nov 18 (a notice of a material company event).
- Exposed: DMIIU
- Market reaction: price tracking starts with the next trading session.
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest and never sell or share it. See our privacy policy.
8-K - Drugs Made In America Acquisition II filed an 8-K with the SEC on Nov 18 (a notice of a material company event).
Directly affected
- DMII Drugs Made In America Acquisition II
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “drugs” (pharma and health) in this story.
- XBI SPDR S&P Biotech ETF
SPDR S&P Biotech ETF: it holds drugmakers and health companies. Linked by “drugs” (pharma and health) in this story.
- LLY Eli Lilly and+25.1% 30d
Eli Lilly and (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “drugs” (pharma and health) in this story.
- JNJ Johnson & Johnson+12.1% 30d
Johnson & Johnson (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “drugs” (pharma and health) in this story.
- PFE Pfizer+5.2% 30d
Pfizer (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “drugs” (pharma and health) in this story.
- MRK Merck+3.5% 30d
Merck (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “drugs” (pharma and health) in this story.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| DMII | +0.00% | +0.00% | base | after close | after close | after close | after close |
| XLV | +2.00% | +1.95% | base | -1.64% | after close | after close | after close |
| XBI | +7.54% | +3.62% | base | -0.31% | after close | after close | after close |
| LLY | +1.56% | +2.06% | base | -2.02% | after close | after close | after close |
| JNJ | +0.58% | +2.60% | base | -1.30% | after close | after close | after close |
| PFE | +3.48% | +1.55% | base | -1.16% | after close | after close | after close |
| MRK | +2.66% | +3.05% | base | -2.68% | after close | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Filed: 2026-11-18 AccNo: 0001477932-26-007137 Size: 223 KB Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Item 8.01: Other Events Item 9.01: Financial Statements…
Source: sec-edgar
How far Drugs Made In America Acquisition II (DMIIU) has moved since 18 Nov 2026
| Company | When | Move | Status |
|---|---|---|---|
| DMII | three days earlier | 0.00% | final price |
| DMII | five days earlier | 0.00% | final price |
| JNJ | that day | -1.30% | still updating |
| JNJ | three days earlier | +2.60% | final price |
| JNJ | five days earlier | +0.58% | final price |
| LLY | that day | -2.02% | still updating |
| LLY | three days earlier | +2.06% | final price |
| LLY | five days earlier | +1.56% | final price |
| MRK | that day | -2.68% | still updating |
| MRK | three days earlier | +3.05% | final price |
| MRK | five days earlier | +2.66% | final price |
| PFE | that day | -1.16% | still updating |
| PFE | three days earlier | +1.55% | final price |
| PFE | five days earlier | +3.48% | final price |
| XBI | that day | -0.31% | still updating |
| XBI | three days earlier | +3.62% | final price |
| XBI | five days earlier | +7.54% | final price |
| XLV | that day | -1.64% | still updating |
| XLV | three days earlier | +1.95% | final price |
| XLV | five days earlier | +2.00% | final price |
Trades by members of Congress and officials in the stocks in this story
- Rep. David J. Taylor sold Eli Lilly (LLY), worth $1,001 - $15,000 on 3 Nov 2026. That is 15 days before publication. Filed 12 Nov 2026. View the filing.
- Rep. Gilbert Cisneros bought Eli Lilly (LLY), worth $1,001 - $15,000 on 20 Oct 2026. That is 29 days before publication. Filed 10 Nov 2026. View the filing.
- Rep. Rohit Khanna bought Eli Lilly (LLY) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 75 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Johnson & Johnson (JNJ) (held by a spouse), worth $15,001 - $50,000 on 7 Oct 2026. That is 42 days before publication. Filed 5 Nov 2026. View the filing.
- Rep. Thomas H. Kean Jr sold Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 30 Sep 2026. That is 49 days before publication. Filed 30 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 54 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Pfizer (PFE) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 75 days before publication. Filed 7 Oct 2026. View the filing.
- Donald J Trump, an executive branch official, bought Pfizer (PFE), worth $100,001 - $250,000 on 21 Aug 2026. That is 89 days before publication. Filed 8 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar sold Merck (MRK), worth $1,001 - $15,000 on 24 Sep 2026. That is 55 days before publication. Filed 7 Oct 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who gains and who loses around Drugs Made In America Acquisition II (DMIIU)
Companies carried with this story
- DMIIU Drugs Made In America Acquisition II
For “8-K - Drugs Made In America Acquisition II Corp. (0002040475) (Filer),” Drugs Made In America Acquisition II (DMIIU) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> DMIIU
Drugs Made In America Acquisition II (DMIIU)
The 18 Nov 2026 story “8-K - Drugs Made In America Acquisition II Corp. (0002040475) (Filer)” names Drugs Made In America Acquisition II (DMIIU) because of this story.
Drugs Made In America Acquisition II (DMIIU) is on the page because SEC 8-K filing -> direct issuer disclosure -> DMIIU
How strong the case is around Drugs Made In America Acquisition II (DMIIU)
14 out of 100Price not final
“8-K - Drugs Made In America Acquisition II Corp. (0002040475) (Filer)” scores 14 out of 100. The score uses 1 source, and 1 linked company. The price is not final yet.